blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1637185

EP1637185 - Controlled-release formulations containing tryptophan and/or 5-hydroxytryptophan [Right-click to bookmark this link]
Former [2006/12]Controlled-release formulations containing tryptophan and/or its metabolites
[2008/12]
StatusNo opposition filed within time limit
Status updated on  26.06.2009
Database last updated on 12.11.2024
Most recent event   Tooltip26.11.2010Lapse of the patent in a contracting state
New state(s): GR		published on 29.12.2010  [2010/52]
Applicant(s)For all designated states
Ambros Pharma S.r.l.
Corso Monforte, 45
20122 Milano / IT
[2006/12]
Inventor(s)01 / Stankov, Bojidar Mihaylov
Largo Cavalieri di Malta 12
20146, MILANO / IT
 [2006/12]
Representative(s)Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [2009/40]Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria 9
20122 Milano / IT
Former [2006/12]Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A., Corso di Porta Vittoria, 9
20122 Milano / IT
Application number, filing date05107894.729.08.2005
[2006/12]
Priority number, dateIT2004MI0168901.09.2004         Original published format: IT MI20041689
[2006/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1637185
Date:22.03.2006
Language:EN
[2006/12]
Type: B1 Patent specification 
No.:EP1637185
Date:20.08.2008
Language:EN
[2008/34]
Search report(s)(Supplementary) European search report - dispatched on:EP27.01.2006
ClassificationIPC:A61P25/24, A61K9/22
[2006/12]
CPC:
A61K9/209 (EP,US); A61K31/405 (EP,US); A61P25/24 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/12]
TitleGerman:Formulierungen mit kontrollierter Freisetzung, die Tryptophan und/oder 5-Hydroxytryptophan enthalten[2008/12]
English:Controlled-release formulations containing tryptophan and/or 5-hydroxytryptophan[2008/12]
French:Formulation à libération controôlée comprenant tryptophane et/or 5-hydroxytryptophane[2008/12]
Former [2006/12]Formulierungen mit kontrollierter Freisetzung, die Tryptophan und/oder seine Metaboliten enthalten
Former [2006/12]Controlled-release formulations containing tryptophan and/or its metabolites
Former [2006/12]Formulation à libération contrôlée comprenant tryptophane et/or les metabolites
Examination procedure20.09.2006Examination requested  [2006/44]
27.10.2006Despatch of a communication from the examining division (Time limit: M04)
27.02.2007Reply to a communication from the examining division
31.05.2007Despatch of a communication from the examining division (Time limit: M04)
28.09.2007Reply to a communication from the examining division
03.03.2008Communication of intention to grant the patent
02.07.2008Fee for grant paid
02.07.2008Fee for publishing/printing paid
Opposition(s)25.05.2009No opposition filed within time limit [2009/31]
Fees paidRenewal fee
24.07.2007Renewal fee patent year 03
10.07.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE20.08.2008
CY20.08.2008
CZ20.08.2008
DK20.08.2008
EE20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
PL20.08.2008
RO20.08.2008
SI20.08.2008
SK20.08.2008
TR20.08.2008
LU29.08.2008
MC31.08.2008
BG20.11.2008
SE20.11.2008
GR21.11.2008
ES01.12.2008
IS20.12.2008
PT20.01.2009
HU21.02.2009
[2010/52]
Former [2010/38]BE20.08.2008
CY20.08.2008
CZ20.08.2008
DK20.08.2008
EE20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
PL20.08.2008
RO20.08.2008
SI20.08.2008
SK20.08.2008
TR20.08.2008
LU29.08.2008
MC31.08.2008
BG20.11.2008
SE20.11.2008
ES01.12.2008
IS20.12.2008
PT20.01.2009
HU21.02.2009
Former [2010/33]BE20.08.2008
CZ20.08.2008
DK20.08.2008
EE20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
PL20.08.2008
RO20.08.2008
SI20.08.2008
SK20.08.2008
LU29.08.2008
MC31.08.2008
BG20.11.2008
SE20.11.2008
ES01.12.2008
IS20.12.2008
PT20.01.2009
Former [2010/24]BE20.08.2008
CZ20.08.2008
DK20.08.2008
EE20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
PL20.08.2008
RO20.08.2008
SI20.08.2008
SK20.08.2008
MC31.08.2008
BG20.11.2008
SE20.11.2008
ES01.12.2008
IS20.12.2008
PT20.01.2009
Former [2010/11]BE20.08.2008
CZ20.08.2008
DK20.08.2008
EE20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
RO20.08.2008
SI20.08.2008
SK20.08.2008
MC31.08.2008
BG20.11.2008
SE20.11.2008
ES01.12.2008
IS20.12.2008
PT20.01.2009
Former [2009/45]BE20.08.2008
CZ20.08.2008
DK20.08.2008
EE20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
RO20.08.2008
SI20.08.2008
SK20.08.2008
MC31.08.2008
BG20.11.2008
ES01.12.2008
IS20.12.2008
PT20.01.2009
Former [2009/27]BE20.08.2008
CZ20.08.2008
DK20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
RO20.08.2008
SI20.08.2008
SK20.08.2008
MC31.08.2008
BG20.11.2008
ES01.12.2008
IS20.12.2008
PT20.01.2009
Former [2009/24]BE20.08.2008
CZ20.08.2008
DK20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
SI20.08.2008
SK20.08.2008
MC31.08.2008
BG20.11.2008
ES01.12.2008
IS20.12.2008
Former [2009/19]BE20.08.2008
DK20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
SI20.08.2008
MC31.08.2008
ES01.12.2008
IS20.12.2008
Former [2009/18]BE20.08.2008
FI20.08.2008
LT20.08.2008
LV20.08.2008
SI20.08.2008
MC31.08.2008
ES01.12.2008
IS20.12.2008
Former [2009/15]FI20.08.2008
LT20.08.2008
LV20.08.2008
SI20.08.2008
MC31.08.2008
ES01.12.2008
IS20.12.2008
Former [2009/14]FI20.08.2008
LT20.08.2008
LV20.08.2008
SI20.08.2008
ES01.12.2008
IS20.12.2008
Former [2009/09]LT20.08.2008
IS20.12.2008
Documents cited:Search[YX]GB1378296  (BEECHAM GROUP LTD) [Y] 1-3,6,8-16,18 * column 1, line 30 - line 34 * * column 1, line 30 - line 34 * [X] 4,5,7,17;
 [Y]EP1077065  (CHUGAI PHARMACEUTICAL CO LTD [JP]) [Y] 1,2 * page 5, paragraph 3 * * page 5, paragraph 20 - paragraph 23 *;
 [Y]US2002147155  (FOSTER WARREN G [CA], et al) [Y] 3,6,8-16,18 * claim 4 * * page 6, paragraph 4 ** page 2, line 53 - line 54 *
by applicant   - J H JUHL, "Fibromylagia and the Serotonin Pathway", ALTERN MED REV, (1998), vol. 3, no. 5L, pages 365 - 375
    - I. P. LAPIN, EPILEPSIA, (1981), vol. 22, page 257
    - WILLIAMS, J.B.W., "A Structured Interview Guide for the Hamilton Depression Rating Scale", ARCHIVES OF GENERAL PSYCHIATRY, AMERICAN MEDICAL ASSOCIATION, (198808), vol. 45, no. 8, pages 742 - 747
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.